Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method

Manual of Clinical Microbiology.

1980 • 14,937 citations

UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION

1984 • 5,344 citations

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

1990 • 943 citations

Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

1988 • 775 citations

Campylobacter pyloridis-associated chronic active antral gastritis

1988 • 572 citations

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori

1996 • 498 citations

Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.

1986 • 368 citations

Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution

1987 • 326 citations

Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori

1991 • 280 citations

IV. Helicobacter pylori and peptic ulceration: Histopathological aspects

1991 • 218 citations

Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers

1995 • 216 citations

The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis

1986 • 178 citations

Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents

1985 • 172 citations

High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori

1992 • 165 citations

Drug therapy for Helicobacter pylori infection: problems and pitfalls.

1990 • 157 citations

Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state

1995 • 135 citations

Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa

1988 • 119 citations

Compliance, Adverse Events and Antibiotic Resistance in Helicobacter pylori Treatment

1993 • 109 citations

V. Helicobacter pylori therapy: Effect on peptic ulcer disease

1991 • 101 citations

TREATMENT STRATEGIES FOR HELICOBACTER PYLORI INFECTION

1993 • 69 citations

Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects.

1996 • 43 citations

Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents againstHelicobacter pylori

1995 • 32 citations

Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth.

1995 • 30 citations

Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases

1995 • 23 citations

Kill kinetics of antimicrobial agents against Helicobacter pylori

1996 • 17 citations

In vitro susceptibility ofHelicobacter pylori to trospectomycin, pirlimycin (U-57930E), mirincamycin (U-24729A) and N-demethyl clindamycin (U-26767A)

1993 • 9 citations

Activity of cefixime against Helicobacter pylori

1993 • 7 citations